SCIENTIFIC PROGRAM
2nd Familial Mediterranean
Fever Meeting
FMF 2024
Program |
||
May 3, 2024 (Friday) | ||
GMT + 3 | ||
16.00-18.00 | Session 1 – Old paradigms, new concepts | Chairpersons: Hasan Yazıcı (Türkiye), Isabelle Touitou (France) |
16.00-16.20 | Unmet needs in FMF | Huri Özdoğan (Türkiye) |
16.20-16.50 | Old paradigms and new concepts in FMF | Eldad Ben-Chetrit (Israel) |
16.50-17.20 | What is FMF? | Ahmet Gül (Türkiye) |
17.20-17.50 | Review of the last two year | Yelda Bilginer (Türkiye) |
19.00 | Welcome Reception | |
May 4, 2024 (Saturday) | ||
GMT + 3 | ||
08.00 – 10.00 | Session 2 – Update: Genetics and Pathogenesis | Chairpersons: Ahmet Gül (Türkiye), Tillmann Kallinich (Germany), Banu Peynircioğlu (Türkiye) |
08.00-08.30 | The changing concept of one gene-one phenotype in monogenic autoinflammatory diseases | Ivona Aksentijevich (USA) |
08.30-09.00 | Regulation of pyrin inflammasome | Mohamed Lamkanfi (Belgium) |
09.00-09.20 | Pyroptosis and clinical implications in FMF | Helmut Wittkowski (Germany) |
09.20-09.40 | Pyrin inflammasome and inflammatory cell migration in FMF | Tayfun Hilmi Akbaba (Türkiye) |
09.40-10.00 | Discussion | |
10.00-10.30 | Coffee Break | |
10.30-12.00 | Session 3 – Update: Genetic diagnosis, environmental factors and microbiome | Chairpersons: Seza Özen(Türkiye), Dorota Rowczenio (UK) |
10.30-11.00 | Update: genetic diagnosis in FMF | Isabelle Touitou (France) |
11.00-11.20 | Non-MEFV gen variants in patients with a FMF phenotype | Eda Tahir Turanlı (Türkiye) |
11.20-11.40 | Syndrome of Undifferentiated Recurrent Fever (SURF) | Marco Gattorno (Italy) |
11.40-12.00 | Impact of enviromental factors and microbiome on the pathogenesis of FMF | Sophie Georgin Lavialle (France) |
12.00-12.30 | Oral presentations | Chairpersons: Fatoş Önen (Türkiye), Ömer Karadağ (Türkiye) |
12.00-12.07 | A clinical overview of unclassified systemic autoinflammatory diseases followed in a Turkish Pediatric Referral Center (Ref: 115) | Şengül Çağlayan (Türkiye) |
12.07-12.14 | Evaluation of patients carrying variants of unknown significance (VUS) in a large FMF cohort: A single center study (Ref: 116) | Taner Coşkuner (Türkiye) |
12.14-12.21 | Exploring S100A8/A9, Neopterin, and MMP3 in Familial Mediterranean Fever: Insights into pathogenesis and diagnostic significance (Ref: 145) | Özgür Can Kılınc (Türkiye) |
12.21-12.28 | Epidemiological features and clinical manifestations in lebanese and Italian subjects with Familial Mediterranean Fever (Ref: 130) | Nour Jaber (Italy) |
12.30-13.30 | Lunch & Poster Reviewing | |
13.30-15.30 | Session 4 – Criteria, registry, geography | Chairpersons: Helmut Wittkowski (Germany), Fatoş Yalçınkaya (Türkiye) |
13.30-13.50 | Pros and cons of diagnostic and classification criteria for FMF | Isabelle Kone-Paut (France) |
13.50-14.10 | Challenges of preparing a registry for FMF | Marco Gattorno (Italy) |
14.10-14.20 | Discussion | |
14.20-15.30 | Round Table: FMF around the world | Chairpersons: Seza Özen (Türkiye), Huri Özdoğan (Türkiye), Eldad Ben-Chetrit (Israel) |
14.20-14.35 | FMF in Japan | Tomohiro Koga (Japan) |
14.35-14.50 | FMF in Italy | Raffaele Manna (Italy) |
14.50-15.05 | FMF in Saudi Arabia | Sulaiman Al-Mayouf (Saudi Arabia) |
15.05-15.30 | Discussion | |
15.30-16.00 | Coffee Break | |
16.00-17.40 | Session 5 – Update: Amyloidosis, associated diseases | Helen Lachmann (UK), Cengiz Korkmaz (Türkiye), Melike Melikoğlu (Türkiye) |
16.00-16.20 | Is amyloidosis still a threat in FMF? | Ahmet Gül (Türkiye) |
16.20-16.40 | Early versus late onset FMF | Piero Portincasa (Italy) |
16.40-17.00 | PFAPA and FMF | Özgür Kasapçopur (Türkiye) |
17:00-17.20 | AS and enthesitis in FMF | Servet Akar (Türkiye) |
17.20-17.40 | Behçet’s disease and FMF | Emire Seyahi (Türkiye) |
17.40-18.08 | Oral presentations | Chairpersons: Mikail Kostik (Russia), Hakan Babaoğlu (Türkiye) |
17.40-17.47 | Gender differences in the diagnosis delay of familial Mediterranean fever: A JIR cohort study (Ref: 91) | Rim Bourguiba (Tunisia) |
17.47-17.54 | Cardiovascular comorbidities in patients with Familial Mediterranean Fever over 45 years of age (Ref: 133) | Sejla Karup (Türkiye) |
17.54-18.01 | Male fertility and paternal effect on pregnancy outcomes in FMF (Ref: 150) | Kerem Parlar (Türkiye) |
18.01-18.08 | Menstrual cycle patterns and dysmenorrhea frequency in adolescent girls with familial Mediterranean fever: Cross-Sectional case-control study (Ref: 106) | Fatma Gül Demirkan (Türkiye) |
May 5, 2024 (Sunday) | ||
GMT + 3 | ||
08.00-10.00 | Session 6a. – Upate:Treatment-I | Chairpersons: Huri Özdoğan(Türkiye), Sophie Georgin-Lavialle (France), Serdal Uğurlu (Türkiye) |
08.00-08.20 | Mechanism of action of colchicine and its expanding efficacy | Eldad Ben-Chetrit (Israel) |
08.20-08.40 | Colchicine response and tolerance in FMF | Seza Özen (Türkiye) |
08.40-09.00 | Anti-IL1 treatment in FMF | Serdal Uğurlu (Türkiye) |
09.00-09.15 | On-demand anti-IL1 treatment | Ilan Ben-Zvi (Israel) |
09.15-09.40 | Efficacy and safety of anti-IL1β treatment in FMF | Helen Lachmann (UK) |
09.40-10.00 | Anti-IL6 treatment FMF | Tomohiro Koga (Japan) |
10.00-10.30 | Coffee Break | |
10.30-12.30 | Session 6b. – Update: Treatment II | Chairpersons: Ahmet Gül(Türkiye), Isabelle Kone-Paut (France) |
10.30-10.50 | Biologic agent combinations in the management of FMF and other autoinflammatory diseases | Abdurrahman Tufan (Türkiye) |
10.50-11.10 | Treat-to target strategies in FMF | Tillmann Kallinich (Germany) |
11.10-11.40 | Discussion for sessions 6a and 6b | |
11.40-12.30 | Session 7 – Transition | Chairpersons: Kenan Barut (Türkiye), Gülay Özgön(Türkiye), Amra Adrovich (Türkiye) |
11.40-12.00 | Transition from pediatric to adult FMF clinics | Betül Sözeri (Türkiye) |
12.00-12.42 | Oral presentations | |
12.00-12.07 | Machine learning algorithms to predict colchicine resistance in Familial Mediterranean Fever (Ref: 158) | Admir Öztürk (Türkiye) |
12.07-12.14 | Comparing the effects of treatments during the attack period on clinical and laboratory data in Familial Mediterranean Fever Patients (Ref: 143) | Elif Kılıç Konte (Türkiye) |
12.14-12.21 | Familial Mediterranean Fever: Effective follow-up of patients who ceased colchicine treatment (Ref: 122) | Gülcan Özomay Baykal (Türkiye) |
12.21-12.28 | Canakinumab treatment in patients with colchicine-resistant familial Mediterranean fever: a multicenter observational study (Ref: 83) | Mete Kara (Türkiye) |
12.28-12.35 | Is canakinumab a good tool for the undifferentiated autoinflammatory diseases: the data of retrospective cohort study (Ref: 108) | Mikhail Kostik (Russia) |
12.35-12.42 | Familial Mediterranean Fever from childhood to adulthood (Ref: 163) | Zeynep Balık (Türkiye) |
12.42-12.50 | Discussion | |
12.50-13.10 | Highlights of the meeting | Sezgin Şahin (Türkiye) |
13.10-13.30 | Future perspectives, presentation of awards, closing remarks | Huri Özdoğan (Türkiye), Eldad Ben-Chetrit (Israel), Serdal Uğurlu (Türkiye) |
D Event Tourism Organization
Professional Congress Organizer (PCO)
İçerenköy Mah. Çayır Cad. No:5 Bay Plaza Kat:12
Ataşehir, İstanbul
Phone: +90 216 573 18 36
Web: www.devent.com.tr
e-mail: istanbul1@devent.com.tr
D Event Tourism Organization